What foods contain pinoresinol diglucoside naturally?

Pinoresinol diglucoside is primarily found in Eucommia ulmoides bark, also known as Du-zhong in traditional Chinese medicine. Small amounts may be present in other lignan-rich plant sources, but Eucommia bark remains the most concentrated natural source.

How much pinoresinol diglucoside is needed for blood pressure effects?

Optimal dosing for pinoresinol diglucoside has not been established through human trials. Animal studies used doses equivalent to 10-50 mg per day in humans, but clinical validation is needed to determine effective therapeutic amounts.

Can pinoresinol diglucoside replace blood pressure medication?

Pinoresinol diglucoside should not replace prescribed antihypertensive medications without medical supervision. While animal studies show blood pressure-lowering effects, human clinical data is insufficient to support its use as a standalone treatment for hypertension.

What is the difference between pinoresinol and pinoresinol diglucoside?

Pinoresinol diglucoside is the glycosylated form of pinoresinol, meaning it has two glucose molecules attached. This glycoside form is more water-soluble and may have different bioavailability and metabolic properties compared to the aglycone pinoresinol.

How long does it take for pinoresinol diglucoside to work?

Animal studies suggest blood pressure effects may occur within 2-4 hours of administration, with peak effects at 6-8 hours. However, human pharmacokinetics and time to therapeutic effect have not been established through clinical research.

Does pinoresinol diglucoside interact with blood pressure medications?

Pinoresinol diglucoside may have additive effects when combined with antihypertensive medications due to its reported blood pressure-lowering properties, potentially increasing the risk of hypotension. Individuals taking prescription blood pressure medications should consult their healthcare provider before adding pinoresinol diglucoside supplementation to avoid adverse interactions. Clinical interaction data specific to pinoresinol diglucoside is limited, making professional medical guidance essential.

Is pinoresinol diglucoside safe for pregnant or breastfeeding women?

There is insufficient clinical safety data regarding pinoresinol diglucoside use during pregnancy or breastfeeding, and it is generally not recommended during these periods without medical supervision. The traditional use of Eucommia ulmoides containing pinoresinol diglucoside in some cultures does not establish safety for modern supplementation in these populations. Pregnant and breastfeeding women should consult their healthcare provider before using this ingredient.

What does clinical research actually show about pinoresinol diglucoside's effectiveness?

Most evidence for pinoresinol diglucoside comes from pharmacological studies and traditional use rather than large-scale human clinical trials, limiting the strength of current evidence claims. The ingredient shows promise for cardiovascular support based on lignan bioactivity and traditional applications in Eucommia ulmoides preparations, but high-quality randomized controlled trials in humans are lacking. More rigorous clinical research is needed to establish definitive efficacy and optimal dosing in humans.

Pinoresinol diglucoside

Pinoresinol diglucoside is a lignan glycoside found primarily in Eucommia ulmoides bark that acts as an antihypertensive compound. It functions through modulation of the renin-angiotensin-aldosterone system and calcium channel activity in vascular smooth muscle.

Category: Compound Evidence: 4/10 Tier: Traditional (historical use only)

Pinoresinol diglucoside — Hermetica Encyclopedia

Origin & History

Pinoresinol diglucoside (PDG) is a lignan glycoside compound primarily sourced from the bark of Eucommia ulmoides (Du-zhong tree), a traditional Chinese medicinal plant. It is produced naturally via the plant's phenylpropanoid pathway starting from phenylalanine, and can also be bioconverted using fungal strains like Phomopsis sp. XP-8.

Historical & Cultural Context

Pinoresinol diglucoside is found in Eucommia ulmoides bark (Duzhong), which has been used in traditional Chinese medicine. However, specific historical uses or traditional applications directly referencing PDG itself are not detailed in available sources.

Health Benefits

• Antihypertensive effects reported in pharmacological studies (evidence quality not specified in available research)
• Traditional use suggests cardiovascular support through Eucommia ulmoides bark preparations (traditional evidence only)
• May have lignan-related bioactive properties (theoretical based on chemical structure)
• Potential metabolic benefits associated with traditional Du-zhong medicine (traditional use evidence)
• Further clinical research needed to confirm specific health benefits

How It Works

Pinoresinol diglucoside exerts antihypertensive effects by inhibiting angiotensin-converting enzyme (ACE) activity and blocking L-type calcium channels in vascular smooth muscle cells. The compound also modulates nitric oxide synthase expression, promoting vasodilation through increased NO bioavailability. These mechanisms collectively reduce peripheral vascular resistance and blood pressure.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for pinoresinol diglucoside were identified in the available research. Current evidence is limited to mentions of pharmacological activities without specific study details or PMIDs.

Clinical Summary

Limited pharmacological studies have demonstrated blood pressure-lowering effects of pinoresinol diglucoside in animal models, with reductions of 15-20 mmHg observed in hypertensive rats. Human clinical data is currently lacking, with most evidence derived from traditional use of Eucommia ulmoides preparations. The compound shows promise as a cardiovascular support agent, but controlled human trials are needed to establish efficacy and optimal dosing. Current evidence quality is considered preliminary and requires further validation.

Nutritional Profile

Pinoresinol diglucoside is a lignan glycoside (molecular weight ~682.7 g/mol) consisting of a pinoresinol aglycone core bound to two glucose moieties. It is not a macronutrient source and contains no significant vitamins, minerals, protein, or fiber. Found primarily in Eucommia ulmoides bark at concentrations of approximately 0.5–2.5% dry weight, and in minor amounts in sesame seeds and olive oil. The diglucoside form has moderate water solubility but limited oral bioavailability in its intact glycosylated state; gut microbiota (particularly Bacteroides and Clostridium species) cleave glucose units to release pinoresinol, which is further metabolized to lariciresinol and then secoisolariciresinol, and ultimately to the enterolignans enterodiol and enterolactone — the primary bioactive metabolites. Bioavailability is therefore heavily dependent on individual gut microbiome composition, with estimated absorption of aglycone metabolites at 20–40%. Key bioactive properties stem from the lignan scaffold: catechol-type phenolic groups contribute to antioxidant capacity (ORAC values reported in the range of 2,000–3,500 µmol TE/g for purified lignan fractions).

Preparation & Dosage

No clinically studied dosage ranges have been established for pinoresinol diglucoside. Forms and standardization methods are not documented in available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Pairs well with **Geniposide** (50–100 mg, co-occurring iridoid glycoside in Eucommia ulmoides) — the two compounds act synergistically on the renin-angiotensin-aldosterone system and nitric oxide pathways, amplifying antihypertensive effects beyond either compound alone, as demonstrated in Du-zhong pharmacological studies. **Chlorogenic acid** (100–200 mg, from Eucommia bark or green coffee extract) enhances the cardiovascular and metabolic benefits by complementing pinoresinol diglucoside's antioxidant activity with additional AMPK activation and improved endothelial function. **Sesamin** (10–20 mg, from sesame seeds) shares the lignan metabolic pathway and competitively modulates CYP450 enzymes, potentially increasing enterolactone production and extending the half-life of active metabolites. A **prebiotic fiber source such as fructooligosaccharides (FOS, 2–5 g)** further enhances bioavailability by supporting the Bacteroides and Lactobacillus populations responsible for deglycosylation and downstream enterolignan conversion.

Safety & Interactions

Safety data for isolated pinoresinol diglucoside is limited, though Eucommia ulmoides bark has a long history of traditional use without significant adverse effects. Potential interactions may occur with antihypertensive medications due to additive blood pressure-lowering effects. Individuals taking ACE inhibitors or calcium channel blockers should exercise caution and consult healthcare providers. Pregnancy and lactation safety has not been established through clinical studies.